This Week in Startups E1089 The Next Unicorns E11: insitro CEO Daphne Koller is revolutionizing drug discovery via machine learning & data, shares insights on remote education from time at Coursera & more
6 snips
Jul 29, 2020 Daphne Koller, CEO of insitro and co-founder of Coursera, is at the forefront of revolutionizing drug discovery using machine learning. She discusses how tech is enhancing drug development efficiency, tackling challenges like high failure rates, and the ethical implications of medical trials. Koller also reflects on the evolution of online education, highlighting its potential to democratize learning and reshape traditional college experiences. The conversation touches on major health issues and the promise of biotech innovations in improving future life expectancy.
AI Snips
Chapters
Transcript
Episode notes
Impact of Early Online Learning
- Early online learning platforms like Coursera initially benefited those lacking access to traditional education.
- They struggled to impact university students who already had these opportunities, but perhaps not in ideal formats.
Effective Online Learning Design
- Create online learning communities with synchronous experiences and deadlines.
- This fosters engagement and combats the tendency of learners to drop off.
Drug Discovery Costs
- Drug discovery is expensive because of high failure rates, not solely FDA regulations.
- Each successful drug carries the cost of many failed programs, necessitating early predictive models.